AQUA BIO TECHNOLOGY ASA: årsregnskap 2025 vs 2024
Grew 2943% on revenue, stronger earnings
approved 2026-04-30; registry 2026-07-28; journal 2026 618296
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for AQUA BIO TECHNOLOGY ASA. Revenue 247.6k NOK → 7.53m NOK (+2942.7%). Net result -233.16m NOK → -24.64m NOK. Equity 6.15m NOK → -489.1k NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded.
Also worth watching: thin equity buffer; paid-in equity reduced; cogs fell. All figures are taken from the published annual accounts for AQUA BIO TECHNOLOGY ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 247.6k NOK to 7.53m NOK (+2942.7% YoY). Calculated
-
↑
Operating result improved
Operating result -62.85m NOK → -12.55m NOK (op. margin -25386.0% → -166.6%). Calculated
-
↑
Net result improved
Net result -233.16m NOK → -24.64m NOK (net margin -94183.9% → -327.1%). Calculated
-
↑
Cash rose
Bank deposits 361.9k NOK → 658.2k NOK (+81.9% YoY). Calculated
-
↑
Payroll decreased
Salary cost 7.53m NOK → 3.17m NOK (3044% → 42% of revenue). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 6.15m NOK → -489.1k NOK (equity ratio 4.1% → -0.4%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -0.4% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 281.52m NOK → 45.57m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
COGS fell
COGS / varekostnad 5.05m NOK → 1.56m NOK (-69.0% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 145.97m NOK → 126.70m NOK. Reported fact